# Trial of the Treatment of Chronic Laryngitis With Amitryptiline

> **NCT02434523** · PHASE2,PHASE3 · TERMINATED · sponsor: **Boston Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Laryngeal Diseases
- Chronic Laryngeal Neuropathy

## Interventions

- **DRUG:** Amitriptyline
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02434523
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** concern regarding study design
- **Last updated:** 2016-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02434523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02434523, "Trial of the Treatment of Chronic Laryngitis With Amitryptiline". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02434523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*